RT Journal Article
SR Electronic
T1 TAVR is Noninferior to Surgical AVR in High-Risk Patients with Aortic Stenosis: Results from the PARTNER Trial
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 3
SP 12
OP 13
DO 10.1177/155989771103003
UL http://mdc.sagepub.com/content/11/3/12.abstract
AB The PARTNER trial now reports that TAVR was noninferior to surgical AVR, the current standard of care, in preventing mortality at 1 year in high-risk patients with symptomatic severe aortic stenosis (Cohort A).